Shanghai Cell Therapy Group Overview
- Founded
-
2013

- Status
-
Private
- Employees
-
70

- Latest Deal Type
-
Later Stage VC
- Investors
-
13
Shanghai Cell Therapy Group General Information
Description
Developer of tumour immune cell therapy treatments. The company operates a cellular diagnosis center and provides immune cell research and treatment services. The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities.
Contact Information
Website
www.shcell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Building A, No. 75 Qianyang Road
- Jiading District
- Shanghai, 201805
- China
+86 400 000 0000
Shanghai Cell Therapy Group Timeline
Shanghai Cell Therapy Group Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC | 08-Feb-2022 | 00000 | Completed | Generating Revenue | ||
7. Later Stage VC (Series D1) | 28-May-2021 | 000.00 | 00000 | 00.000 | Completed | Generating Revenue |
6. Later Stage VC (Series C2) | 01-Dec-2018 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
5. Later Stage VC (Series C1) | 01-Oct-2018 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
4. Early Stage VC | 26-Jun-2018 | 000.00 | Completed | Generating Revenue | ||
3. Early Stage VC (Series B) | 18-Apr-2016 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
2. Early Stage VC (Series A) | 03-Jun-2014 | $20.8M | $20.8M | 000.00 | Completed | Generating Revenue |
1. Joint Venture | 29-Nov-2013 | Completed | Generating Revenue |
Shanghai Cell Therapy Group Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of tumour immune cell therapy treatments. The company operates a cellular diagnosis center and provides immune
Biotechnology
Shanghai, China
70
As of 2015
00000
0000000000 0
00000
Shanghai Cell Therapy Group Competitors (38)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mabworks Biotech | Private Equity-Backed | Beijing, China | 000 | 00000 | 0000000 0000 | 00000 |
000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
000000000000000 | Venture Capital-Backed | Saint Louis, MO | 00 | 000.00 | 00000000000 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
000000000000 | Formerly VC-backed | Beijing, China | 0000 | 00000 | 00000000 | 00000 |
Shanghai Cell Therapy Group Patents
Shanghai Cell Therapy Group Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4081545-A2 | Cell expressing immune modulatory molecules and system for expressing immune modulatory molecules | Pending | 28-Dec-2019 | 0000000000 | |
CA-3161286-A1 | Promoter having high activity in activated t-cell | Pending | 15-Nov-2019 | 0000000000 | |
EP-4060042-A1 | Promoter having high activity in activated t-cell | Pending | 15-Nov-2019 | 0000000000 | 0 |
JP-2023502098-A | Promoter with high activity in activated t cells | Pending | 15-Nov-2019 | ||
US-20220372481-A1 | Promoter having high activity in activated t-cell | Pending | 15-Nov-2019 | C12N15/85 |
Shanghai Cell Therapy Group Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Na Ding Ph.D | Chief Operating Officer | ||
Qijun Qian MD | Chairman & Executive Director |
Shanghai Cell Therapy Group Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Qijun Qian MD | Shanghai Cell Therapy Group | Chairman & Executive Director | 000 0000 |
Shanghai Cell Therapy Group Signals
Shanghai Cell Therapy Group Investors (13)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Xiyang Investment | Venture Capital | Minority | 000 0000 | 000000 0 | |
CCB International | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Jiuzhou Venture | Venture Capital | Minority | 000 0000 | 000000 0 | |
Sun Rock Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
China Pacific Life Insurance | Asset Manager | Minority | 000 0000 | 000000 0 |